![](/img/cover-not-exists.png)
Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting Glioblastoma
Müller, Nadja, Michen, Susanne, Tietze, Stefanie, Töpfer, Katrin, Schulte, Alexander, Lamszus, Katrin, Schmitz, Marc, Schackert, Gabriele, Pastan, Ira, Temme, AchimVolume:
38
Language:
english
Journal:
Journal of Immunotherapy
DOI:
10.1097/cji.0000000000000082
Date:
June, 2015
File:
PDF, 705 KB
english, 2015